Skip to main
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI is well-positioned in the emerging market of AI-driven medical diagnostics, with its DeepView System offering a unique and efficient way to assess wound healing potential. With a large and under-penetrated market opportunity, as well as recent funding from BARDA to support the development and commercialization of the DeepView System, the company has a strong potential for growth. However, risks exist in terms of competition, delays in regulatory and clinical timelines, and limited reimbursement. Based on the company's current revenue guidance, the analyst estimates a strong CAGR in the coming years and assigns a Buy rating with a $4 price target on the stock.

Bears say

Spectral AI is expected to recognize revenue from its existing BARDA contract and achieve its regulatory and clinical milestones, but risks such as limited awareness of the technology, competition, and delays to timelines may impede its success. The company has reported an increase in R&D revenue and promising cash reserves but has yet to bring a commercial technology to the market.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.